tirzepatide safer than ozempic Why You Might Tolerate One Weight Loss Drug Better Another Ozempic vs Tirzepatide: Choose the

A 2022 study published in Diabetes, Obesity and Metabolism found that adults over 50 achieved clinically significant weight loss on semaglutide, with cardiovascular and metabolic risk reductions comparable to younger cohorts, though the authors noted the importance of individualized monitoring protocols for older patients given the higher baseline prevalence of comorbidities

Key takeaways Tirzepatide is the active ingredient in the brand-name drugs Mounjaro and Zepbound, while semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus

It should not have been

For example, in the studies carried out by Kelly et al